PeptideDB

Bismuth potassium citrate

CAS: 57644-54-9 F: C12H10BiK3O14 W: 704.47

Bismuth potassium citrate (Bismuth tripotassium dicitrate) is an orally active gastric mucosal protector and has antibac
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Bismuth potassium citrate (Bismuth tripotassium dicitrate) is an orally active gastric mucosal protector and has antibacterial and anti-inflammatory activity. Bismuth potassium citrate relieves stomach pain, resists H. pylori growth and repairs gastric mucosa. Bismuth potassium citrate combined with Omeprazole (HY-B0113) has a safe and high efficacy against H. pylori infection, which is promising for research of peptic ulcers, gastric cancer and tubulointerstitial nephritis[1][2][3][4][5][6].
In Vivo Bismuth potassium citrate (50 mg/kg,口服,每日一次,14 天) 在大鼠胃中可以改善随着年龄增长而增加的对有害物质的易感性[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model:
CAS 57644-54-9
Formula C12H10BiK3O14
Molar Mass 704.47
Appearance 固体
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. S M Hinsull, et al. Effect of colloidal bismuth subcitrate on age related gastric lesions in the rat. Gut. 1991 Apr;32(4):355-60. doi: 10.1136/gut.32.4.355. [2]. Luo HY, et al. Pharmacokinetic and Safety Study of Bismuth Potassium Citrate Formulations in Healthy Subjects[J]. Drugs R D. 2024 Mar;24(1):81-87. [3]. JIANG J X. Efficacy of compound bismuth potassium citrate capsules combined with omeprazole in eradication of Helicobacter pylori infection: A clinical study[J]. Academic Journal of Second Military Medical University, 2010: 973-977. [4]. Mikhailova M, et al. BISMUT-INDUCED ONSET OF ACUTE TUBULOINTERSTICIAL NEPHRITIS: A CLINICAL CASE[J]. [5]. Naidenko E S, et al. Obtaining bismuth-potassium citrate[J]. Chemistry for Sustainable Development, 2012, 20: 523-528. [6]. Xuan Y, et al. High-security multifunctional nano-bismuth-sphere-cluster prepared from oral gastric drug for ct/pa dual-mode imaging and chemo-photothermal combined therapy in vivo[J]. Advanced Functional Materials, 2019, 29(18): 1900017.